(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

AI Chipmaker Cerebras Systems Seeks $4.8 Billion in Upsized IPO
18:02

Lyft Earnings Miss Estimates After Global Expansion Push
25:56

Wall Street Poised for Bonus Increases in ‘Year of the Bank’
26:24